Company Update

Hindustan Biosciences Ltd has announced the publication of its financial results for the quarter ended June 30, 2025. The company reported total revenue of 0.335 Cr, marking a decline from both the previous quarter and the same period last year.

Net profit for the quarter stood at 0.014 Cr, significantly lower than prior periods, resulting in earnings per share (EPS) of 0.01. This update provides shareholders with crucial insight into the company's recent operational performance and financial health, reflecting a challenging quarter.